Clinical features of LMN syndromes
Typical pattern of weakness | |||||||
---|---|---|---|---|---|---|---|
Symmetry | Proximal/distal | Limb predominance | Bulbar involvement | Disease progression | Investigation findings | ||
SMA | Symmetrical | Proximal>distal | LL>UL | Yes | Slowly progressive | Homozygous deletion exon 7 SMN1 gene (94%); small percentage compound heterozygous for SMN1 deletion and an intragenic mutation of SMN1 | |
SBMA | Symmetrical or asymmetrical | Proximal>distal | LL>UL | Yes | Slowly progressive | X-linked trinucleotide CAG expansion (>39 repeats) androgen receptor gene | |
dHMN | Symmetrical | Distal | LL>UL; exception dHMN V: UL predominance | Rare; laryngeal involvement in dHMN VII | Slowly progressive | Mutations in HSPB1, HSPB8, BSCL2, GARS, DCTN1, TRP4, SETX | |
Immune | GBS | Symmetrical | Distal>proximal | UL and LL | May occur | Acute: weakness usually progresses over hours-days | Anti-GM1 IgG antibody and anti-GD1a IgG antibody in AMAN variant |
MMN | Asymmetrical | Distal>proximal | UL | No | Slowly progressive | Anti-GM1 IgM in 30–80% | |
CIDP (motor) | Symmetrical or asymmetrical | Proximal and distal | UL and LL | No | Relapsing-remitting | Anti-GM1 IgM often negative | |
MND (LMN variants) | Sporadic | Asymmetrical | Distal>proximal | Variable | May occur ∼10% | Median survival 3–4 years | Anti-GM1 IgM antibodies may be present but typically low titre Features of cortical hyperexcitability on TMS |
Flail arm | Symmetrical | Proximal>distal | UL | Not at onset; may develop later in disease course | Median survival ∼5 years | ||
Flail leg | Asymmetrical | Distal>proximal | LL | Not at onset; may develop later in disease course | Median survival ∼6 years | ||
Genetic | Asymmetrical | Variable | Variable | Variable | Variable; rapid and slowly progressive forms described | Mutations in SOD1, FUS, VAPB, and CHMP2B | |
MMA | Asymmetrical | Distal>proximal | UL involvement more frequent than LL | No | Insidious onset, slow progression, followed by stabilisation | MR findings: lower cervical cord atrophy, asymmetric cord flattening, and/or anterior displacement of the dorsal dura on neck flexion | |
Segmental LMN disease | Asymmetrical | Distal or proximal | UL | No | Insidious onset, slow progression up to 20 years | MRI may reveal ‘snake eyes’ appearance | |
Polio | Acute poliomyelitis | Asymmetrical | Proximal>distal | LL>UL | 5–35% of patients | Acute: weakness usually progresses over hours-days | PCR poliovirus from CSF |
Postpolio syndrome | Asymmetrical | Variable | Variable | Variable | Slowly progressive; fatigue and pain common | Changes of chronic denervation with reinnervation on needle electromyography |
AMAN, acute motor axonal neuropathy; CHMP2B, chromatin-modifying protein 2b; CIDP, chronic inflammatory demyelinating polyneuropathy; CSF, cerebrospinal fluid; dHMN, distal hereditary motor neuropathy; FUS, fused in sarcoma; GBS, Guillain-Barré syndrome; LL, lower limb; LMN, lower motor neuron; MMA, monomelic amyotrophy; MMN, multifocal motor neuropathy; MND, motor neuron disease; SBMA, spinobulbar muscular atrophy; SMA, spinal muscular atrophy; SOD1, superoxide dismutase type 1; TMS, transcranial magnetic stimulation; UL, upper limb; VAPB, vesicle-associated membrane protein/synaptobrevin-associated membrane protein B.